Key takeaways: The agreement between the Manhattan District Attorney’s Office and the House Judiciary Committee will allow the former prosecutor to testify in the congressional…
Posts tagged as “U.S. Circuit Court of Appeal”
The Supreme Court is expected to make a decision Wednesday on a request by the federal government to immediately block a lower court ruling that would restrict access to the abortion pill mifepristone. The case originated in Judge Matthew Kacsmaryk’s court in Amarillo, Texas, and the outcome of this decision could have a major impact on access to mifepristone and the ability of women to make decisions about their own reproductive health. The Department of Justice has appealed to the Fifth Circuit Court of Appeals and the Supreme Court has temporarily blocked the appeals court ruling while the justices consider what next steps to take.
This week has seen a flurry of activity in the abortion debate, with a federal court ruling partially overturning a lower court ruling that had said mifepristone sales should be stopped, and Florida Governor Ron DeSantis signing into law a six-week abortion ban. DeSantis, who is rumored to be considering a presidential run, has been oddly muted on the abortion issue since the fall of Roe v. Wade, avoiding laying out a federal platform before jumping into the race.
The Society of Family Planning's report reveals that medication abortions provided by virtual-only providers have increased by 136% since the Supreme Court eliminated the constitutional right to abortion in June 2022. Total abortions decreased by 2%, and the Guttmacher Institute found that medication abortions already accounted for more than half of all US abortions in 2020. The 5th U.S. Circuit Court of Appeals recently ruled to preserve but narrow access to an abortion pill across the U.S., and the rate of medication abortions is likely to continue to rise.
The 5th U.S. Circuit Court of Appeals has granted a temporary reprieve to access to the abortion pill mifepristone, allowing the FDA's initial approval of the drug to remain in place but with tighter rules than before. The ruling leaves considerable uncertainty over access to the drug, but it does provide a temporary solution until the full case is heard.
A federal judge has issued a ruling to stay the FDA's approval of the abortion drug mifepristone, in response to a lawsuit brought by anti-abortion groups in Texas. The ruling invalidates the FDA's 23-year-old approval of the drug, and the groups have urged the 5th U.S. Circuit Court of Appeals to let the ruling stand. The case is likely to be taken to the Supreme Court, and the outcome could have a significant impact on access to the medication.
The Supreme Court has agreed to review a case that could have a major impact on the Consumer Financial Protection Bureau (CFPB). The case centers around the Appropriations Clause of the Constitution, which states that "no money shall be drawn from the Treasury, but in consequence of appropriations made by law." The CFPB was created in the wake of the 2008 financial crisis and its regulations are now at risk of being overturned by the Supreme Court. The court is expected to hear the case in the spring of 2021.
The 5th Circuit Court of Appeals has ruled that a federal law prohibiting people subject to domestic violence restraining orders from possessing firearms is unconstitutional, in line with the Supreme Court's 6-3 decision in New York State Rifle & Pistol Association, Inc. v. Bruen. This ruling is a major victory for gun rights advocates, and could be appealed to the Supreme Court to decide the fate of the law.